Epizyme Inc (NASDAQ:EPZM)

15.85
Delayed Data
As of Apr 20
 -0.20 / -1.25%
Today’s Change
9.30
Today|||52-Week Range
21.40
+26.29%
Year-to-Date

Today’s Trading

Previous close16.05
Today’s open16.00
Day’s range15.60 - 16.20
Volume218,882
Average volume (3 months)443,027
Market cap$1.3B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+41.87%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+212.77%
P/E ratioNM
Price/Sales86.33
Price/Book5.21

Competitors

----
FPRXFive Prime Therapeut...+0.10+0.62%
RTRXRetrophin Inc+0.01+0.04%
SGMOSangamo Therapeutics...-0.15-0.78%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 7, 2018
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$8.0M
Annual profit (last year)-$110.2M
Net profit margin-1,376.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts